Erratum to: Adenosine Monophosphate-Activated Protein Kinase (AMPK) as a New Target for Antidiabetic Drugs: A Review on Metabolic, Pharmacological and Chemical Considerations by Gruzman et al., Rev Diabet Stud 2009, 6(1):13-36
AUTOR(ES)
Gruzman, Arie
FONTE
SBDR - Society for Biomedical Diabetes Research
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2779009Documentos Relacionados
- Adenosine Monophosphate-Activated Protein Kinase (AMPK) as a New Target for Antidiabetic Drugs: A Review on Metabolic, Pharmacological and Chemical Considerations
- Dorsal Hindbrain 5′-Adenosine Monophosphate-Activated Protein Kinase as an Intracellular Mediator of Energy Balance
- Keystone Symposium on Antibodies as Drugs: March 27–April 1, 2009, Whistler, BC CA
- Guanosine 3',5'-cyclic monophosphate-activated conductance studied in a truncated rod outer segment of the toad.
- ENCONTRO DE PRODUÇÃO CIENTÍFICA DA EMBRAPA ALGODÃO - EPC 2009, 4., 2009, Campina Grande.